Updated Jul 16, 2026
Nichols Weston has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Based on the SEC filing context, Nichols Weston serves as a Director on Crinetics Pharmaceuticals, Inc.'s Board of Directors as of June 22, 2026. No additional public biographical details are available in this context. If multiple people share this name, verification with company disclosures is recommended.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | CRNX | Crinetics Pharmaceuticals, Inc. | A — Grant or award | 5.9K | $0.00 |
Based on the SEC filing context, Nichols Weston serves as a Director on Crinetics Pharmaceuticals, Inc.'s Board of Directors as of June 22, 2026. No additional public biographical details are available in this context. If multiple people share this name, verification with company disclosures is recommended.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nichols Weston profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.